Molecular basis of rifampin resistance in Mycobacterium leprae.
Rifampin is currently the most potent drug used in leprosy control programs. We show that the rifampin resistance which emerged in nine patients with lepromatous leprosy, who had received rifampin monotherapy, stemmed from mutations in the rpoB gene, which encodes the beta subunit of RNA polymerase...
Gardado en:
| Publicado en: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society for Microbiology (ASM)
1993
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC187686/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8460911/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.37.3.414 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|